Qiagen Nv stock is traded at $49.89, with a volume of 1,642,137. It is down -0.42% in the last 24 hours and up +9.79% over the past month. Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
Previous Close:
$50.10
Open:
$50.09
24h Volume:
1,642,137
Relative Volume:
0.40
Market Cap:
$10.30B
Revenue:
$2.10B
Net Income/Loss:
$402.17M
P/E Ratio:
25.77
EPS:
$1.94
Net Cash Flow:
$403.87M
1W Performance:
-0.87%
1M Performance:
+9.79%
6M Performance:
+52.57%
1Y Performance:
+11.74%
1-Day Range:
$49.83$50.14
1-Week Range:
$49.83$50.55
52-Week Range:
$32.53$57.82
Qiagen Nv Stock (QGEN) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS